Home/ Stocks/ DERM

Journey Medical Corporation Common Stock

DERM XNAS

$6.43 -0.10 (-1.53%) ▼ 15-min delayed

Open

$6.62

High

$6.77

Low

$6.40

Volume

390.9K

Market Cap

$179.80M

About Journey Medical Corporation Common Stock

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 58 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$15.96M	$-2,230,000	$-0.08
FY 2025	$61.86M	$-11,431,000	$-0.47
Q3 2025	$17.63M	$-2,315,000	$-0.09
Q2 2025	$15.01M	$-3,796,000	$-0.16

Related Market News

No specific coverage for DERM yet. Check out our latest market news or earnings calendar.

Get DERM Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Journey Medical Corporation Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.